Empagliflozin: a new treatment option for patients with type 2 diabetes mellitus. [electronic resource]
Producer: 20151216Description: 519-35 p. digitalISSN:- 1699-3993
- Animals
- Benzhydryl Compounds -- adverse effects
- Biomarkers -- blood
- Blood Glucose -- drug effects
- Diabetes Mellitus, Type 2 -- blood
- Glucosides -- adverse effects
- Humans
- Hypoglycemic Agents -- adverse effects
- Kidney Tubules, Proximal -- drug effects
- Renal Elimination -- drug effects
- Sodium-Glucose Transporter 2 -- metabolism
- Sodium-Glucose Transporter 2 Inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.